Behind the deal spree, Celgene continues to cautiously explore neurosciences
Two years ago during a lunch with a group of reporters at the JPMorgan confab, then Celgene CEO (now executive chairman) Bob Hugin got my …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
